IMC Chicago’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
IMC Chicago's GILD Position: Q4 2025 in Review
IMC Chicago sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 43,865 shares — an estimated $5.33M sold.
IMC Chicago first reported a position in GILD in Q4 2019 and held it in 12 quarters. The position peaked at $21.5M in Q4 2022. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- IMC Chicago reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- IMC Chicago sold 43,865 Gilead Sciences shares in Q4 2025, an estimated $5.33M.
- IMC Chicago first reported a position in Gilead Sciences in Q4 2019 and held it in 12 quarters.
- IMC Chicago's Gilead Sciences position peaked at $21.5M in Q4 2022.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.